Trial Profile
CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Therapeutic Use
- Acronyms CORDLESS
- Sponsors Auxilium Pharmaceuticals; Endo Pharmaceuticals
- 15 May 2015 Results published in the Endo Pharmaceuticals media release.
- 16 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Oct 2013 New trial record